Lyme Disease Testing Market Outlook Signals Expansion To $16.46 Billion Through 2030

The Business Research Company

The Business Research Company's Lyme Disease Testing Market Outlook Signals Expansion To $16.46 Billion Through 2030

LONDON, GREATER LONDON, UNITED KINGDOM, August 14, 2026 /EINPresswire.com/ -- "The market for Lyme disease testing has experienced substantial growth recently, reflecting increasing attention to the diagnosis and management of this tick-borne illness. As awareness and technological advancements continue to evolve, the sector is positioned for further expansion in the coming years. Let’s explore the current market size, key drivers, regional dynamics, and emerging trends shaping the future of Lyme disease testing.

Market Size and Growth Outlook for Lyme Disease Testing
The Lyme disease testing market has shown significant growth, with its size projected to rise from $10.68 billion in 2025 to $11.67 billion in 2026, representing a compound annual growth rate (CAGR) of 9.3%. This upward trend in recent years is largely driven by factors such as the increasing incidence of Lyme disease, insufficient awareness about early detection, continued dependence on traditional serological tests, greater hospital-based diagnostic activities, and intensified research in tick-borne diseases.

Download a free sample of the lyme disease testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25817&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Looking ahead, the market is expected to expand robustly, reaching $16.46 billion by 2030 at a CAGR of 9.0%. Key contributors to this growth include the adoption of AI-assisted diagnostic tools, the rising popularity of home-testing kits, the development of multi-disease testing panels, increased government funding for monitoring tick-borne diseases, and the integration of cloud-based laboratory data management systems. Major trends anticipated during this period involve the broader rollout of point-of-care testing, advancements in home-based Lyme diagnostics, the use of multi-pathogen panels for tick-borne diseases, rapid test kits gaining market traction, and the customization of diagnostic protocols.

Understanding Lyme Disease Testing and Its Purpose
Lyme disease testing involves medical procedures to detect infection by Borrelia burgdorferi, the bacterium transmitted primarily through tick bites that cause Lyme disease. The main goal of these tests is to provide an accurate diagnosis, especially in patients exhibiting symptoms like fever, fatigue, or the characteristic bull’s-eye rash, which are early indicators of infection.

View the full lyme disease testing market report:
https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

The Role of Tick-Borne Illnesses in Driving Market Demand
A significant factor fueling the growth of the Lyme disease testing market is the rising prevalence of tick-borne illnesses. These diseases are transmitted to humans via infected ticks, which are small blood-feeding parasites commonly found in grassy, wooded, or rural environments. The expanding geographic distribution of ticks, driven by climate change, has increased human exposure to these parasites, resulting in higher infection rates and greater demand for diagnostic testing.

Moreover, tick-borne illnesses are the primary transmission route for Lyme disease, making early detection through testing critical for effective disease management. For example, in March 2025, the U.S. Centers for Disease Control and Prevention (CDC) reported over 89,000 Lyme disease cases in 2023, underscoring the ongoing high incidence and public health burden posed by tick-borne infections. This persistent prevalence is a key driver behind the expanding testing market.

Regional Market Leadership and Growth Potential
In 2025, North America dominated the Lyme disease testing market, holding the largest regional share. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth over the forecast period. The market analysis includes a comprehensive overview of regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, highlighting global trends and opportunities in Lyme disease diagnostics.

What’s new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X